论文部分内容阅读
《世界临床药物》由上海医药工业研究院主管主办,为中国科技核心期刊,中国科技论文统计源期刊,中国学术期刊综合评价数据库来源期刊,华东地区优秀期刊。被多家权威数据库如CNKI、NSTL、维普资讯、万方数据、CMCC、CMCI,以及美国CA和波兰IC等收录,全国各大医药学高等院校图书馆均有收藏。在国内医药、医疗卫生企事业单位颇具影响。依托主办单位药物研究开发实力及其在全国医药行业的影响力,凭借上海乃至全国各大医院和医学药学高等院校专家教授编委参与和支持,本刊30余年坚持不懈倡导安全用药、合理用药理念,积极推进国内临床用药水平的提高。
The “World Clinical Drugs” is sponsored by the director of Shanghai Institute of Pharmaceutical Industry. It is the core journal of science and technology in China, the source journal of Chinese science and technology papers, the source journal of China Academic Journal Comprehensive Evaluation Database, and the outstanding journal of East China. By a number of authoritative databases such as CNKI, NSTL, VIP information, Wanfang data, CMCC, CMCI, and the United States CA and Poland IC included, the major medical colleges and universities have collections of libraries. In the domestic medicine, medical and health enterprises and institutions quite influential. Relying on the strength of the sponsor drug research and development and its influence in the pharmaceutical industry across the country, with Shanghai and the country’s major hospitals and medical colleges and universities of experts and professors editorial board participation and support, more than 30 years adhere to unscrupulous safety medication, rational use of medicine Concept, and actively promote the improvement of clinical use of drugs in China.